BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20547426)

  • 1. HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes.
    de Graaf MT; de Beukelaar JW; Haasnoot GW; Levering WH; Rogemond V; Didelot A; Honnorat J; Gratama JW; Smitt PA
    J Neuroimmunol; 2010 Sep; 226(1-2):147-9. PubMed ID: 20547426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
    de Beukelaar JW; Verjans GM; van Norden Y; Milikan JC; Kraan J; Hooijkaas H; Sintnicolaas K; Gratama JW; Sillevis Smitt PA
    Cancer Immunol Immunother; 2007 Sep; 56(9):1501-6. PubMed ID: 17597332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B and T cell imbalances in CSF of patients with Hu-antibody associated PNS.
    de Graaf M; de Beukelaar J; Bergsma J; Kraan J; van den Bent M; Klimek M; van Norden Y; Kusuma A; Smitt PS; Gratama JW
    J Neuroimmunol; 2008 Mar; 195(1-2):164-70. PubMed ID: 18358542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
    Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
    Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes.
    de Beukelaar JW; Sillevis Smitt PA; Hop WC; Kraan J; Hooijkaas H; Verjans GM; Gratama JW
    Eur J Neurol; 2007 Dec; 14(12):1383-91. PubMed ID: 18028190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells in paraneoplastic neurological syndromes.
    Tani T; Tanaka K; Idezuka J; Nishizawa M
    J Neuroimmunol; 2008 May; 196(1-2):166-9. PubMed ID: 18455243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological course of long-term surviving patients with SCLC and anti-Hu syndrome.
    Poepel A; Jarius S; Heukamp LC; Urbach H; Elger CE; Bien CG; Voltz R
    J Neurol Sci; 2007 Dec; 263(1-2):145-8. PubMed ID: 17706677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Hu-antibody-associated paraneoplastic neurological syndrome accompanying testicular cancer.
    Sano T; Tanaka K; Ito N
    Int J Urol; 2010 Jan; 17(1):99. PubMed ID: 20377832
    [No Abstract]   [Full Text] [Related]  

  • 10. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Small cell lung cancer and anti-Hu syndrome].
    Prim N; Mennecier B; Behr C; Fraisse P; Echaniz-Laguna A; Tranchant C; Quoix E
    Rev Mal Respir; 2010 Mar; 27(3):261-5. PubMed ID: 20359620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
    Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
    J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative response of peripheral blood mononuclear cells in anti-Hu antibody-associated patients with paraneoplastic neurological syndrome and their depressant effect on small cell lung cancer cells.
    Yin L; Qu H; Chen Q
    Mol Med Rep; 2015 Mar; 11(3):1595-600. PubMed ID: 25412252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
    Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
    Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis.
    Bernal F; Graus F; Pifarré A; Saiz A; Benyahia B; Ribalta T
    Acta Neuropathol; 2002 May; 103(5):509-15. PubMed ID: 11935268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy.
    Molinuevo JL; Graus F; Serrano C; Reñe R; Guerrero A; Illa I
    Ann Neurol; 1998 Dec; 44(6):976-80. PubMed ID: 9851446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis.
    Sabater L; Gómez-Choco M; Saiz A; Graus F
    J Neuroimmunol; 2005 Dec; 170(1-2):186-90. PubMed ID: 16165222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease.
    Martinetti M; Biagi F; Badulli C; Feurle GE; Müller C; Moos V; Schneider T; Marth T; Marchese A; Trotta L; Sachetto S; Pasi A; De Silvestri A; Salvaneschi L; Corazza GR
    Gastroenterology; 2009 Jun; 136(7):2289-94. PubMed ID: 19208355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.